40 results on '"Steichen C"'
Search Results
2. Successful pre-implantation genetic diagnosis for Hirschsprung disease
- Author
-
Burlet, P, Steichen, C, Hesters, L, Gigarel, N, Kerbrat, V, Frydman, R, Munnich, A, Amiel, J, Frydman, N, and Steffann, J
- Published
- 2011
- Full Text
- View/download PDF
3. Barriers and Advances in Kidney Preservation
- Author
-
Steichen, C., Giraud, S., Bon, D., Barrou, B., Badet, L., Salamé, E., Kerforne, T., Allain, G., Roumy, J., Jayle, C., Hannaert, P., Hauet, T., and Thuillier, R.
- Subjects
Article Subject - Abstract
Despite the fact that a significant fraction of kidney graft dysfunctions observed after transplantation is due to ischemia-reperfusion injuries, there is still no clear consensus regarding optimal kidney preservation strategy. This stems directly from the fact that as of yet, the mechanisms underlying ischemia-reperfusion injury are poorly defined, and the role of each preservation parameter is not clearly outlined. In the meantime, as donor demography changes, organ quality is decreasing which directly increases the rate of poor outcome. This situation has an impact on clinical guidelines and impedes their possible harmonization in the transplant community, which has to move towards changing organ preservation paradigms: new concepts must emerge and the definition of a new range of adapted preservation method is of paramount importance. This review presents existing barriers in transplantation (e.g., temperature adjustment and adequate protocol, interest for oxygen addition during preservation, and clear procedure for organ perfusion during machine preservation), discusses the development of novel strategies to overcome them, and exposes the importance of identifying reliable biomarkers to monitor graft quality and predict short and long-term outcomes. Finally, perspectives in therapeutic strategies will also be presented, such as those based on stem cells and their derivatives and innovative models on which they would need to be properly tested.
- Published
- 2018
- Full Text
- View/download PDF
4. Human cardiomyocytes derived from induced pluripotent stem cells
- Author
-
Steichen, C., primary, Jacquard-Fevai, M., additional, Brishoual, S., additional, and Hauet, T., additional
- Published
- 2019
- Full Text
- View/download PDF
5. Autologous cell/gene therapy approach of hemophilia B using patient specific induced Pluripotent Stem Cells
- Author
-
Luce, E., primary, Steichen, C., additional, Antonietta, M., additional, Goulinet, S., additional, Lambert, T., additional, Weber, A., additional, Nguyen, T.H., additional, Christophe, O., additional, and Dubart-Kupperschmitt, A., additional
- Published
- 2018
- Full Text
- View/download PDF
6. PS-145 - Autologous cell/gene therapy approach of hemophilia B using patient specific induced Pluripotent Stem Cells
- Author
-
Luce, E., Steichen, C., Antonietta, M., Goulinet, S., Lambert, T., Weber, A., Nguyen, T.H., Christophe, O., and Dubart-Kupperschmitt, A.
- Published
- 2018
- Full Text
- View/download PDF
7. 295 HUMAN INDUCED PLURIPOTENT STEM CELLS (iPSCs) REPROGRAMMED WITH HOME-MADE-mRNAs: A TOOL FOR STEM-CELL DERIVED HEPATOCYTE STUDIES
- Author
-
Steichen, C., primary, Luce, E., additional, Goulinet-Mainot, S., additional, Tosca, L., additional, Tachdjian, G., additional, Burks, D., additional, Weber, A., additional, Marie, J., additional, and Dubart-Kupperschmitt, A., additional
- Published
- 2013
- Full Text
- View/download PDF
8. P31 Successful preimplantation genetic diagnosis (PGD) test for Hirschsprung disease
- Author
-
Burlet, P., primary, Frydman, N., additional, Steichen, C., additional, Gigarel, N., additional, Hesters, L., additional, Kerbrat, V., additional, Tachdjian, G., additional, Munnich, A., additional, Bonnefont, J-P., additional, Frydman, R., additional, and Steffann, J., additional
- Published
- 2010
- Full Text
- View/download PDF
9. FAST NEUTRON ATTENUATION ANALYSIS FOR A SNAP REACTOR SHADOW SHIELD USING THE FLEXIBLE MONTE CARLO CODE, FMC-N.
- Author
-
Steichen, C., primary
- Published
- 1963
- Full Text
- View/download PDF
10. Improved Long Pulse Ionization Simulation Using Pulsed Reactors.
- Author
-
Steichen, C. U., Retzler, J. P., and Apodaca, L.
- Published
- 1973
- Full Text
- View/download PDF
11. Adult and embryonic frontal cortex transplants after frontal cortex ablation enhance recovery on a reinforced alternation task
- Author
-
Kesslak, J.P., primary, Brown, L., additional, Steichen, C., additional, and Cotman, C.W., additional
- Published
- 1986
- Full Text
- View/download PDF
12. P02-14 In vitro 2D and 3D kidney models to study the nephrotoxic response of uranium exposure.
- Author
-
Frerejacques, M., Powell, V., Giraud, S., Manoury, A., Finet, C., Bouvier-Capely, C., Steichen, C., Hauet, T., and Gueguen, Y.
- Subjects
- *
URANIUM , *KIDNEYS - Published
- 2024
- Full Text
- View/download PDF
13. Successful preimplantation genetic diagnosis (PGD) test for Hirschsprung disease.
- Author
-
Burlet, P., Frydman, N., Steichen, C., Gigarel, N., Hesters, L., Kerbrat, V., Tachdjian, G., Munnich, A., Bonnefont, J.-P., Frydman, R., and Steffann, J.
- Subjects
- *
PREIMPLANTATION genetic diagnosis , *HIRSCHSPRUNG'S disease , *PRENATAL diagnosis , *GENETIC disorder diagnosis , *PEDIATRIC diagnosis , *DIAGNOSIS - Abstract
Hirschsprung disease (HSCR, aganglionic megacolon) represents the main genetic cause of functional intestinal obstruction with an incidence of 1/5000 live births. The major gene is the tyrosine kinase receptor RET. Identification of mutation in the RET coding sequence theoretically offers the possibility to perform prenatal (PND) or preimplantation genetic diagnosis (PGD). However, such procedures remain controversial. Currently available surgical therapies, although life-saving, are associated with an unsatisfactory long-term prognosis for many. In this context, at-risk couples often consider PGD as the better option to give birth to unaffected children. A couple whose male partner was affected with HSCR gave birth to two severely affected children, and was referred to our PGD centre. The mutation c.751insGC was identified in exon 4 of the RET gene at an heterozygous state in all three affected patients. We developed a specific single cell protocol in order to select unaffected embryos based on mutation analysis and an intron 4 intragenic marker segregation. PGD was performed on two blastomeres from four embryos. Three were unaffected and two of them subjected to transfer, resulting in one twin pregnancy and the birth of two heathy children. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
14. FAST NEUTRON ATTENUATION ANALYSIS FOR A SNAP REACTOR SHADOW SHIELD USING THE FLEXIBLE MONTE CARLO CODE, FMC-N.
- Author
-
Steichen, C
- Published
- 1963
- Full Text
- View/download PDF
15. THE EXPERIMENTAL DETERMINATION AND ANALYTICAL VERIFICATION OF THE AGE OF Pu- Be SOURCE NEUTRONS IN GRAPHITE (thesis)
- Author
-
Steichen, C
- Published
- 1960
16. MONTE CARLO EVALUATION OF FAST NEUTRON FLUXES AND HEATING IN THE S8DS NEUTRON SHIELD
- Author
-
Steichen, C
- Published
- 1965
17. Successful Derivation of Hepatoblasts, Cholangiocytes and Hepatocytes from Simian Induced Pluripotent Stem Cells.
- Author
-
Luce E, Steichen C, Abed S, Weber A, Leboulch P, Maouche-Chrétien L, and Dubart-Kupperschmitt A
- Subjects
- Animals, Cell Culture Techniques methods, Cell Differentiation, Epithelial Cells, Hepatocytes metabolism, Humans, Liver, Induced Pluripotent Stem Cells
- Abstract
The use of primary cells in human liver therapy is limited by a lack of cells. Induced pluripotent stem cells (iPSCs) represent an alternative to primary cells as they are infinitely expandable and can be differentiated into different liver cell types. The aim of our work was to demonstrate that simian iPSCs (siPSCs) could be used as a new source of liver cells to be used as a large animal model for preclinical studies. We first differentiated siPSCs into a homogenous population of hepatoblasts (siHBs). We then separately differentiated them into hepatocytes (siHeps) and cholangiocytes (siChols) expressing respective specific markers and displaying epithelial polarity. Moreover, we showed that polarized siChols can self-organize into 3D structures. These results should facilitate the deciphering of liver development and open the way to exploring co-culture systems that could be assessed during preclinical studies, including in autologous monkey donors, for regenerative medicine purposes.
- Published
- 2022
- Full Text
- View/download PDF
18. In vitro recovery of FIX clotting activity as a marker of highly functional hepatocytes in a hemophilia B iPSC model.
- Author
-
Luce E, Steichen C, Allouche M, Messina A, Heslan JM, Lambert T, Weber A, Nguyen TH, Christophe O, and Dubart-Kupperschmitt A
- Subjects
- Animals, Biomarkers, Cell Differentiation, Factor IX genetics, Hepatocytes, Humans, Hemophilia B genetics, Hemophilia B therapy, Induced Pluripotent Stem Cells, Liver, Artificial
- Abstract
Background and Aims: Pluripotent stem cell-derived hepatocytes differentiated in monolayer culture are known to have more fetal than adult hepatocyte characteristics. If numerous studies tend to show that this immature phenotype might not necessarily be an obstacle to their use in transplantation, other applications such as drug screening, toxicological studies, or bioartificial livers are reliant on hepatocyte functionality and require full differentiation of hepatocytes. New technologies have been used to improve the differentiation process in recent years, usually evaluated by measuring the albumin production and CYP450 activity. Here we used the complex production and most importantly the activity of the coagulation factor IX (FIX) produced by mature hepatocytes to assess the differentiation of hemophilia B (HB) patient's induced pluripotent stem cells (iPSCs) in both monolayer culture and organoids., Approach and Results: Indeed, HB is an X-linked monogenic disease due to an impaired activity of FIX synthesized by hepatocytes in the liver. We have developed an in vitro model of HB hepatocytes using iPSCs generated from fibroblasts of a severe HB patient. We used CRISPR/Cas9 technology to target the genomic insertion of a coagulation factor 9 minigene bearing the Padua mutation to enhance FIX activity. Noncorrected and corrected iPSCs were differentiated into hepatocytes under both two-dimensional and three-dimensional differentiation protocols and deciphered the production of active FIX in vitro. Finally, we assessed the therapeutic efficacy of this approach in vivo using a mouse model of HB., Conclusions: Functional FIX, whose post-translational modifications only occur in fully mature hepatocytes, was only produced in corrected iPSCs differentiated in organoids. Immunohistochemistry analyses of mouse livers indicated a good cell engraftment, and the FIX activity detected in the plasma of transplanted animals confirmed rescue of the bleeding phenotype., (© 2021 The Authors. Hepatology published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases.)
- Published
- 2022
- Full Text
- View/download PDF
19. Rho GTPases in kidney physiology and diseases.
- Author
-
Steichen C, Hervé C, Hauet T, and Bourmeyster N
- Subjects
- Actins metabolism, rho-Associated Kinases metabolism, rac1 GTP-Binding Protein metabolism, rho GTP-Binding Proteins metabolism, Podocytes
- Abstract
Rho family GTPases are molecular switches best known for their pivotal role in dynamic regulation of the actin cytoskeleton, but also of cellular morphology, motility, adhesion and proliferation. The prototypic members of this family (RhoA, Rac1 and Cdc42) also contribute to the normal kidney function and play important roles in the structure and function of various kidney cells including tubular epithelial cells, mesangial cells and podocytes. The kidney's vital filtration function depends on the structural integrity of the glomerulus, the proximal portion of the nephron. Within the glomerulus, the architecturally actin-based cytoskeleton podocyte forms the final cellular barrier to filtration. The glomerulus appears as a highly dynamic signalling hub that is capable of integrating intracellular cues from its individual structural components. Dynamic regulation of the podocyte cytoskeleton is required for efficient barrier function of the kidney. As master regulators of actin cytoskeletal dynamics, Rho GTPases are therefore of critical importance for sustained kidney barrier function. Dysregulated activities of the Rho GTPases and of their effectors are implicated in the pathogenesis of both hereditary and idiopathic forms of kidney diseases. Diabetic nephropathy is a progressive kidney disease that is caused by injury to kidney glomeruli. High glucose activates RhoA/Rho-kinase in mesangial cells, leading to excessive extracellular matrix production (glomerulosclerosis). This RhoA/Rho-kinase pathway also seems involved in the post-transplant hypertension frequently observed during treatment with calcineurin inhibitors, whereas Rac1 activation was observed in post-transplant ischaemic acute kidney injury.
- Published
- 2022
- Full Text
- View/download PDF
20. Molecular Networking for Drug Toxicities Studies: The Case of Hydroxychloroquine in COVID-19 Patients.
- Author
-
Ferron PJ, Le Daré B, Bronsard J, Steichen C, Babina E, Pelletier R, Hauet T, Morel I, Tarte K, Reizine F, Clément B, Fromenty B, and Gicquel T
- Subjects
- Aged, Antiviral Agents therapeutic use, COVID-19 complications, COVID-19 metabolism, Cell Line, Cell Survival drug effects, Chemical and Drug Induced Liver Injury metabolism, Correlation of Data, Drug-Related Side Effects and Adverse Reactions, Fatty Acids pharmacology, Fatty Liver complications, Fatty Liver metabolism, Female, Humans, Hydroxychloroquine therapeutic use, Linear Models, Male, Metabolic Networks and Pathways, Middle Aged, Obesity complications, Obesity metabolism, Risk Factors, Antiviral Agents adverse effects, Antiviral Agents metabolism, Hydroxychloroquine adverse effects, Hydroxychloroquine metabolism, COVID-19 Drug Treatment
- Abstract
Using drugs to treat COVID-19 symptoms may induce adverse effects and modify patient outcomes. These adverse events may be further aggravated in obese patients, who often present different illnesses such as metabolic-associated fatty liver disease. In Rennes University Hospital, several drug such as hydroxychloroquine (HCQ) have been used in the clinical trial HARMONICOV to treat COVID-19 patients, including obese patients. The aim of this study is to determine whether HCQ metabolism and hepatotoxicity are worsened in obese patients using an in vivo/in vitro approach. Liquid chromatography high resolution mass spectrometry in combination with untargeted screening and molecular networking were employed to study drug metabolism in vivo (patient's plasma) and in vitro (HepaRG cells and RPTEC cells). In addition, HepaRG cells model were used to reproduce pathophysiological features of obese patient metabolism, i.e., in the condition of hepatic steatosis. The metabolic signature of HCQ was modified in HepaRG cells cultured under a steatosis condition and a new metabolite was detected (carboxychloroquine). The RPTEC model was found to produce only one metabolite. A higher cytotoxicity of HCQ was observed in HepaRG cells exposed to exogenous fatty acids, while neutral lipid accumulation (steatosis) was further enhanced in these cells. These in vitro data were compared with the biological parameters of 17 COVID-19 patients treated with HCQ included in the HARMONICOV cohort. Overall, our data suggest that steatosis may be a risk factor for altered drug metabolism and possibly toxicity of HCQ.
- Published
- 2021
- Full Text
- View/download PDF
21. A Sodium Oxalate-Rich Diet Induces Chronic Kidney Disease and Cardiac Dysfunction in Rats.
- Author
-
Crestani T, Crajoinas RO, Jensen L, Dima LL, Burdeyron P, Hauet T, Giraud S, and Steichen C
- Subjects
- Animals, Blood Pressure, Female, Glomerular Filtration Rate, Heart Rate, Hematocrit, Male, Oxalic Acid administration & dosage, Oxalic Acid pharmacokinetics, Rats, Rats, Wistar, Diet adverse effects, Heart Diseases etiology, Hyperoxaluria etiology, Oxalic Acid toxicity, Renal Insufficiency, Chronic etiology
- Abstract
Chronic kidney disease (CKD) is a worldwide public health issue affecting 14% of the general population. However, research focusing on CKD mechanisms/treatment is limited because of a lack of animal models recapitulating the disease physiopathology, including its complications. We analyzed the effects of a three-week diet rich in sodium oxalate (OXA diet) on rats and showed that, compared to controls, rats developed a stable CKD with a 60% reduction in glomerular filtration rate, elevated blood urea levels and proteinuria. Histological analyses revealed massive cortical disorganization, tubular atrophy and fibrosis. Males and females were sensitive to the OXA diet, but decreasing the diet period to one week led to GFR significance but not stable diminution. Rats treated with the OXA diet also displayed classical CKD complications such as elevated blood pressure and reduced hematocrit. Functional cardiac analyses revealed that the OXA diet triggered significant cardiac dysfunction. Altogether, our results showed the feasibility of using a convenient and non-invasive strategy to induce CKD and its classical systemic complications in rats. This model, which avoids kidney mass loss or acute toxicity, has strong potential for research into CKD mechanisms and novel therapies, which could protect and postpone the use of dialysis or transplantation.
- Published
- 2021
- Full Text
- View/download PDF
22. Combining cell-based therapy and normothermic machine perfusion for kidney graft conditioning has gone one step further.
- Author
-
Steichen C and Erpicum P
- Subjects
- Humans, Kidney, Perfusion, Kidney Transplantation, Reperfusion Injury
- Published
- 2021
- Full Text
- View/download PDF
23. Oxidative Stress Evaluation in Ischemia Reperfusion Models: Characteristics, Limits and Perspectives.
- Author
-
Chazelas P, Steichen C, Favreau F, Trouillas P, Hannaert P, Thuillier R, Giraud S, Hauet T, and Guillard J
- Subjects
- Animals, Cell Line, Humans, Models, Molecular, Reactive Oxygen Species, Disease Models, Animal, Oxidative Stress, Reperfusion Injury metabolism
- Abstract
Ischemia reperfusion injury is a complex process consisting of a seemingly chaotic but actually organized and compartmentalized shutdown of cell function, of which oxidative stress is a key component. Studying oxidative stress, which results in an imbalance between reactive oxygen species (ROS) production and antioxidant defense activity, is a multi-faceted issue, particularly considering the double function of ROS, assuming roles as physiological intracellular signals and as mediators of cellular component damage. Herein, we propose a comprehensive overview of the tools available to explore oxidative stress, particularly in the study of ischemia reperfusion. Applying chemistry as well as biology, we present the different models currently developed to study oxidative stress, spanning the vitro and the silico, discussing the advantages and the drawbacks of each set-up, including the issues relating to the use of in vitro hypoxia as a surrogate for ischemia. Having identified the limitations of historical models, we shall study new paradigms, including the use of stem cell-derived organoids, as a bridge between the in vitro and the in vivo comprising 3D intercellular interactions in vivo and versatile pathway investigations in vitro. We shall conclude this review by distancing ourselves from "wet" biology and reviewing the in silico, computer-based, mathematical modeling, and numerical simulation options: (a) molecular modeling with quantum chemistry and molecular dynamic algorithms, which facilitates the study of molecule-to-molecule interactions, and the integration of a compound in a dynamic environment (the plasma membrane...); (b) integrative systemic models, which can include many facets of complex mechanisms such as oxidative stress or ischemia reperfusion and help to formulate integrated predictions and to enhance understanding of dynamic interaction between pathways.
- Published
- 2021
- Full Text
- View/download PDF
24. Electrical stimulation applied during differentiation drives the hiPSC-CMs towards a mature cardiac conduction-like cells.
- Author
-
Crestani T, Steichen C, Neri E, Rodrigues M, Fonseca-Alaniz MH, Ormrod B, Holt MR, Pandey P, Harding S, Ehler E, and Krieger JE
- Subjects
- Biomarkers metabolism, Cell Differentiation, Cell- and Tissue-Based Therapy methods, Connexins genetics, Connexins metabolism, Contactin 2 genetics, Contactin 2 metabolism, Electric Stimulation, Gene Expression, Heart Conduction System cytology, Heart Conduction System physiology, Homeobox Protein Nkx-2.5 genetics, Homeobox Protein Nkx-2.5 metabolism, Homeodomain Proteins genetics, Homeodomain Proteins metabolism, Humans, Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels genetics, Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels metabolism, Induced Pluripotent Stem Cells cytology, Muscle Proteins genetics, Muscle Proteins metabolism, Myocytes, Cardiac cytology, NAV1.5 Voltage-Gated Sodium Channel genetics, NAV1.5 Voltage-Gated Sodium Channel metabolism, Potassium Channels genetics, Potassium Channels metabolism, Primary Cell Culture, Transcription Factors genetics, Transcription Factors metabolism, Troponin I genetics, Troponin I metabolism, beta Catenin genetics, beta Catenin metabolism, Gap Junction alpha-5 Protein, Action Potentials physiology, Calcium metabolism, Induced Pluripotent Stem Cells physiology, Myocytes, Cardiac physiology
- Abstract
Human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs) resemble fetal cardiomyocytes and electrical stimulation (ES) has been explored to mature the differentiated cells. Here, we hypothesize that ES applied at the beginning of the differentiation process, triggers both differentiation of the hiPSC-CMs into a specialized conduction system (CS) phenotype and cell maturation. We applied ES for 15 days starting on day 0 of the differentiation process and found an increased expression of transcription factors and proteins associated with the development and function of CS including Irx3, Nkx2.5 and contactin 2, Hcn4 and Scn5a, respectively. We also found activation of intercalated disc proteins (Nrap and β-catenin). We detected ES-induced CM maturation as indicated by increased Tnni1 and Tnni3 expression. Confocal micrographs showed a shift towards expression of the gap junction protein connexin 40 in ES hiPSC-CM compared to the more dominant expression of connexin 43 in controls. Finally, analysis of functional parameters revealed that ES hiPSC-CMs exhibited faster action potential (AP) depolarization, longer intracellular Ca
2+ transients, and slower AP duration at 90% of repolarization, resembling fast conducting fibers. Altogether, we provided evidence that ES during the differentiation of hiPSC to cardiomyocytes lead to development of cardiac conduction-like cells with more mature cytoarchitecture. Thus, hiPSC-CMs exposed to ES during differentiation can be instrumental to develop CS cells for cardiac disease modelling, screening individual drugs on a precison medicine type platform and support the development of novel therapeutics for arrhythmias., Competing Interests: Declaration of competing interest The authors confirm that there are no conflicts of interest., (Copyright © 2020 Elsevier Inc. All rights reserved.)- Published
- 2020
- Full Text
- View/download PDF
25. Urine-derived stem/progenitor cells: A focus on their characterization and potential.
- Author
-
Burdeyron P, Giraud S, Hauet T, and Steichen C
- Abstract
Cell therapy, i.e ., the use of cells to repair an affected tissue or organ, is at the forefront of regenerative and personalized medicine. Among the multiple cell types that have been used for this purpose [including adult stem cells such as mesenchymal stem cells or pluripotent stem cells], urine-derived stem cells (USCs) have aroused interest in the past years. USCs display classical features of mesenchymal stem cells such as differentiation capacity and immunomodulation. Importantly, they have the main advantage of being isolable from one sample of voided urine with a cheap and unpainful procedure, which is broadly applicable, whereas most adult stem cell types require invasive procedure. Moreover, USCs can be differentiated into renal cell types. This is of high interest for renal cell therapy-based regenerative approaches. This review will firstly describe the isolation and characterization of USCs. We will specifically present USC phenotype, which is not an object of consensus in the literature, as well as detail their differentiation capacity. In the second part of this review, we will present and discuss the main applications of USCs. These include use as a substrate to generate human induced pluripotent stem cells, but we will deeply focus on the use of USCs for cell therapy approaches with a detailed analysis depending on the targeted organ or system. Importantly, we will also focus on the applications that rely on the use of USC-derived products such as microvesicles including exosomes, which is a strategy being increasingly employed. In the last section, we will discuss the remaining barriers and challenges in the field of USC-based regenerative medicine., Competing Interests: Conflict-of-interest statement: The authors declare that they have no conflict of interest., (©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
26. Combining Kidney Organoids and Genome Editing Technologies for a Better Understanding of Physiopathological Mechanisms of Renal Diseases: State of the Art.
- Author
-
Steichen C, Giraud S, and Hauet T
- Abstract
Kidney organoids derived from pluripotent stem cells became a real alternative to the use of in vitro cellular models or in vivo animal models. Indeed, the comprehension of the key steps involved during kidney embryonic development led to the establishment of protocols enabling the differentiation of pluripotent stem cells into highly complex and organized structures, composed of various renal cell types. These organoids are linked with one major application based on iPSC technology advantage: the possibility to control iPSC genome, by selecting patients with specific disease or by genome editing tools such as CRISPR/Cas9 system. This allows the generation of kidney organoïds which recapitulate important physiopathological mechanisms such as cyst formation in renal polycystic disease for example. This review will focus on studies combining these both cutting edge technologies i.e., kidney organoid differentiation and genome editing and will describe what are the main advances performed in the comprehension of physiopathological mechanisms of renal diseases, as well as discuss remaining technical barriers and perspectives in the field., (Copyright © 2020 Steichen, Giraud and Hauet.)
- Published
- 2020
- Full Text
- View/download PDF
27. Genomic integrity of human induced pluripotent stem cells: Reprogramming, differentiation and applications.
- Author
-
Steichen C, Hannoun Z, Luce E, Hauet T, and Dubart-Kupperschmitt A
- Abstract
Ten years after the initial generation of induced pluripotent stem cells (hiPSCs) from human tissues, their potential is no longer questioned, with over 15000 publications listed on PubMed, covering various fields of research; including disease modeling, cell therapy strategies, pharmacology/toxicology screening and 3D organoid systems. However, despite evidences that the presence of mutations in hiPSCs should be a concern, publications addressing genomic integrity of these cells represent less than 1% of the literature. After a first overview of the mutation types currently reported in hiPSCs, including karyotype abnormalities, copy number variations, single point mutation as well as uniparental disomy, this review will discuss the impact of reprogramming parameters such as starting cell type and reprogramming method on the maintenance of the cellular genomic integrity. Then, a specific focus will be placed on culture conditions and subsequent differentiation protocols and how their may also trigger genomic aberrations within the cell population of interest. Finally, in a last section, the impact of genomic alterations on the possible usages of hiPSCs and their derivatives will also be exemplified and discussed. We will also discuss which techniques or combination of techniques should be used to screen for genomic abnormalities with a particular focus on the necessary quality controls and the potential alternatives., (©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
28. Efficacy of the natural oxygen transporter HEMO 2 life ® in cold preservation in a preclinical porcine model of donation after cardiac death.
- Author
-
Kaminski J, Hannaert P, Kasil A, Thuillier R, Leize E, Delpy E, Steichen C, Goujon JM, Zal F, and Hauet T
- Subjects
- Adenosine Triphosphate analysis, Animals, Cold Temperature, Male, Organ Preservation Solutions, Perfusion, Swine, Vascular Endothelial Growth Factor A analysis, Hemoglobins, Organ Preservation methods
- Abstract
The growing use of marginal organs for transplantation pushes current preservation methods toward their limits, and the need for improvement is pressing. We previously demonstrated the benefits of M101, a natural extracellular oxygen carrier compatible with hypothermia, for the preservation of healthy renal grafts in a porcine model of autotransplantation. Herein, we use a variant of this preclinical model to evaluate M101 potential benefits both in static cold storage (CS) and in machine perfusion (MP) preservation in the transplantation outcomes for marginal kidneys. In the CS arm, despite the absence of obvious benefits within the first 2 weeks of follow-up, M101 dose-dependently improved long-term function, normalizing creatininemia after 1 and 3 months. In the MP arm, M101 improved short- and long-term functional outcomes as well as tissue integrity. Importantly, we provide evidence for the additivity of MP and M101 functional effects, showing that the addition of the compound further improves organ preservation, by reducing short-term function loss, with no loss of function or tissue integrity recorded throughout the follow-up. Extending previous observations with healthy kidneys, the present results point at the M101 oxygen carrier as a viable strategy to improve current organ preservation methods in marginal organ transplantation., (© 2019 Steunstichting ESOT.)
- Published
- 2019
- Full Text
- View/download PDF
29. Influence of Hypoxic Preservation Temperature on Endothelial Cells and Kidney Integrity.
- Author
-
Giraud S, Steichen C, Couturier P, Tillet S, Mallet V, Coudroy R, Goujon JM, Hannaert P, and Hauet T
- Subjects
- Animals, Apoptosis, Cell Adhesion, Cell Hypoxia, Cell Shape, Endothelial Cells ultrastructure, Immunity, Innate, Mitochondria metabolism, Necrosis, Oxygen analysis, Oxygen blood, Phenotype, Pressure, Swine, Tissue Preservation, Endothelial Cells pathology, Kidney pathology, Temperature
- Abstract
Ischemia-reperfusion (IR) injury is unavoidable during organ transplantation and impacts graft quality. New paradigms are emerging including preservation at higher temperature than "hypothermia" or "cold": although 4°C remains largely used for kidney preservation, recent studies challenged this choice. We and others hypothesized that a higher preservation temperature, closer to physiological regimen, could improve organ quality. For this purpose, we used an in vitro model of endothelial cells exposed to hypoxia-reoxygenation sequence (mimicking IR) and an ex vivo ischemic pig kidneys static storage model. In vitro , 19°C, 27°C, and 32°C provided protection against injuries versus 4°C, by reducing cell death, mitochondrial dysfunction, leukocyte adhesion, and inflammation. However, ex vivo , the benefits of 19°C or 32°C were limited, showing similar levels of tissue preservation damage. Ex vivo 4°C-preserved kidneys displayed a trend towards reduced damage, including apoptosis. Macrophage infiltration, tubulitis, and necrosis were increased in the 19°C and 32°C versus 4°C preserved kidneys. Thus, despite a trend for an advantage of subnormothermia as preservation temperature, our in vitro and ex vivo models bring different insights in terms of preservation temperature effect. This study suggests that temperature optimization for kidney preservation will require thorough investigation, combining the use of complementary relevant models and the design of elaborated preservation solution and new technologies.
- Published
- 2019
- Full Text
- View/download PDF
30. Emerging therapeutic strategies for transplantation-induced acute kidney injury: protecting the organelles and the vascular bed.
- Author
-
Melis N, Thuillier R, Steichen C, Giraud S, Sauvageon Y, Kaminski J, Pelé T, Badet L, Richer JP, Barrera-Chimal J, Jaisser F, Tauc M, and Hauet T
- Subjects
- Acute Kidney Injury etiology, Acute Kidney Injury physiopathology, Animals, Humans, Mineralocorticoid Receptor Antagonists pharmacology, Mitochondria pathology, Molecular Targeted Therapy, Reperfusion Injury etiology, Reperfusion Injury physiopathology, Acute Kidney Injury drug therapy, Kidney Transplantation adverse effects, Reperfusion Injury drug therapy
- Abstract
Introduction: Renal ischemia-reperfusion injury (IRI) is a significant clinical challenge faced by clinicians in a broad variety of clinical settings such as perioperative and intensive care. Renal IRI induced acute kidney injury (AKI) is a global public health concern associated with high morbidity, mortality, and health-care costs. Areas covered: This paper focuses on the pathophysiology of transplantation-related AKI and recent findings on cellular stress responses at the intersection of 1. The Unfolded protein response; 2. Mitochondrial dysfunction; 3. The benefits of mineralocorticoid receptor antagonists. Lastly, perspectives are offered to the readers. Expert opinion: Renal IRI is caused by a sudden and temporary impairment of blood flow to the organ. Defining the underlying cellular cascades involved in IRI will assist us in the identification of novel interventional targets to attenuate IRI with the potential to improve transplantation outcomes. Targeting mitochondrial function and cellular bioenergetics upstream of cellular damage may offer several advantages compared to targeting downstream inflammatory and fibrosis processes. An improved understanding of the cellular pathophysiological mechanisms leading to kidney injury will hopefully offer improved targeted therapies to prevent and treat the injury in the future.
- Published
- 2019
- Full Text
- View/download PDF
31. [Kidney organoids].
- Author
-
Steichen C, Giraud S, and Hauet T
- Subjects
- Animals, Cell Differentiation, Drug Evaluation, Preclinical, Gene Editing, Humans, Induced Pluripotent Stem Cells, Kidney embryology, Kidney physiology, Organoids physiology, Pluripotent Stem Cells
- Abstract
This review focus on kidney organoids derived from pluripotent stem cells, which become a real alternative to the use of in vitro cellular models or in vivo animals models. The comprehension of the key steps involved during kidney embryonic development led to the establishment of protocols enabling the differentiation of pluripotent stem cells into kidney organoids that are highly complex and organized structures, composed of various renal cell types. These mini-organs are endowed with major applications: the possibility to control iPSC genome (by selecting patients with specific disease or by genome editing) allows the generation of kidney organoïds which recapitulate important physiopathological mechanisms such as cyste formation in renal polycystic disease. Kidney organoids can also be used in high-throughput screening to fasten the screening of nephrotoxic/therapeutic compounds. Finally, kidney organoids have a huge interest in the context of tissue repair, which remains for now a challenging goal linked with technological barriers that need still to be overcome., (© 2019 médecine/sciences – Inserm.)
- Published
- 2019
- Full Text
- View/download PDF
32. Hypercholesterolemia-induced increase in plasma oxidized LDL abrogated pro angiogenic response in kidney grafts.
- Author
-
Kerforne T, Favreau F, Khalifeh T, Maiga S, Allain G, Thierry A, Dierick M, Baulier E, Steichen C, and Hauet T
- Subjects
- Adult, Animals, Aorta pathology, Biomarkers metabolism, Cell Proliferation drug effects, Diet, High-Fat, Endothelial Cells metabolism, Female, Humans, Hypercholesterolemia physiopathology, Kidney Function Tests, Macrophages pathology, Male, Middle Aged, Swine, Thrombospondins metabolism, Vascular Endothelial Growth Factor A blood, Vascular Remodeling, Hypercholesterolemia blood, Kidney Transplantation, Lipoproteins, LDL blood, Neovascularization, Physiologic
- Abstract
Background: Renal transplantation is increasingly associated with the presence of comorbidity factors such as dyslipidemia which could influence the graft outcome. We hypothesized that hypercholesterolemia could affect vascular repair processes and promote post-transplant renal vascular remodeling through the over-expression of the anti-angiogenic thrombospondin-1 interacting with vascular endothelial growth factor-A levels., Methods: We tested this hypothesis in vitro, in vivo and in a human cohort using (1) endothelial cells; (2) kidney auto-transplanted pig subjected (n = 5) or not (n = 6) to a diet enriched in cholesterol and (3) a renal transplanted patient cohort (16 patients)., Results: Cells exposed to oxidized LDL showed reduced proliferation and an increased expression of thrombospondin-1. In pigs, 3 months after transplantation of kidney grafts, we observed a deregulation of the hypoxia inducible factor 1a-vascular endothelial growth factor-A axis induced in cholesterol-enriched diet animals concomitant with an overexpression of thrombospondin-1 and a decrease in cortical microvessel density promoting vascular remodeling. In patients, hypercholesterolemia was associated with decreased vascular endothelial growth factor-A plasma levels during early follow up after renal transplantation and increased chronic graft dysfunction., Conclusions: These results support a potential mechanism through which a high fat-diet impedes vascular repair in kidney graft and suggest the value of controlling cholesterolemia in recipient even at the early stage of renal transplantation.
- Published
- 2019
- Full Text
- View/download PDF
33. Dynamic transcriptomic analysis of Ischemic Injury in a Porcine Pre-Clinical Model mimicking Donors Deceased after Circulatory Death.
- Author
-
Giraud S, Steichen C, Allain G, Couturier P, Labourdette D, Lamarre S, Ameteau V, Tillet S, Hannaert P, Thuillier R, and Hauet T
- Subjects
- Animals, Biomarkers, Death, Down-Regulation genetics, Kidney physiopathology, Kidney Transplantation methods, Organ Preservation methods, Reperfusion Injury metabolism, Swine, Tissue Donors, Warm Ischemia methods, Cardiovascular System physiopathology, Reperfusion Injury genetics, Reperfusion Injury prevention & control, Transcriptome genetics
- Abstract
Due to organ shortage, clinicians are prone to consider alternative type of organ donors among them donors deceased after circulatory death (DCD). However, especially using these organs which are more prone to graft dysfunction, there is a need to better understand mechanistic events ocuring during ischemia phase and leading to ischemia/reperfusion injuries (IRI). The aim of this study is to provide a dynamic transcriptomic analysis of preclinical porcine model kidneys subjected to ischemic stress mimicking DCD donor. We compared cortex and corticomedullary junction (CMJ) tissues from porcine kidneys submitted to 60 min warm ischemia (WI) followed by 0, 6 or 24 hours of cold storage in University of Wisconsin solution versus control non-ischemic kidneys (n = 5 per group). 29 cortex genes and 113 CMJ genes were significantly up or down-regulated after WI versus healthy kidneys, and up to 400 genes were regulated after WI followed by 6 or 24 hours of cold storage (p < 0.05). Functionnal enrichment analysis (home selected gene kinetic classification, Gene-ontology-biological processes and Gene-ontology-molecular-function) revealed relevant genes implication during WI and cold storage. We uncovered targets which we will further validate as biomarkers and new therapeutic targets to optimize graft kidney quality before transplantation and improve whole transplantation outcome.
- Published
- 2018
- Full Text
- View/download PDF
34. Human Induced Pluripotent Stem (hiPS) Cells from Urine Samples: A Non-Integrative and Feeder-Free Reprogramming Strategy.
- Author
-
Steichen C, Si-Tayeb K, Wulkan F, Crestani T, Rosas G, Dariolli R, Pereira AC, and Krieger JE
- Subjects
- Animals, Cell Culture Techniques, Feeder Cells, Female, Humans, Male, Mice, Plasmids genetics, Transfection, Cell Separation, Cellular Reprogramming, Induced Pluripotent Stem Cells cytology, Urine cytology
- Abstract
Human induced pluripotent stem (hiPS) cell technology has already revolutionized some aspects of fundamental and applied research such as study of disease mechanisms and pharmacology screening. The first clinical trial using hiPS cell-derived cells began in Japan, only 10 years after the publication of the proof-of concept article. In this exciting context, strategies to generate hiPS cells have evolved quickly, tending towards non-invasive protocols to sample somatic cells combined with "safer" reprogramming strategies. In this unit, we describe a protocol combining both of these advantages to generate hiPS cells with episomal plasmid transfection from urine samples of individuals carrying the desired genotype. Based on previous published works, this simplified protocol requires minimal equipment and reagents, and is suitable both for scientists familiar with the hiPS cells technology and neophytes. HiPS cells displaying classical features of pluripotency and suitable for all desired downstream applications are generated rapidly (<10 weeks) and with high efficiency. © 2017 by John Wiley & Sons, Inc., (Copyright © 2017 John Wiley & Sons, Inc.)
- Published
- 2017
- Full Text
- View/download PDF
35. The potential of induced pluripotent stem cell derived hepatocytes.
- Author
-
Hannoun Z, Steichen C, Dianat N, Weber A, and Dubart-Kupperschmitt A
- Subjects
- Animals, Cell Differentiation, Hepatocytes, Humans, Liver, Artificial, Regenerative Medicine, Induced Pluripotent Stem Cells
- Abstract
Orthotopic liver transplantation remains the only curative treatment for liver disease. However, the number of patients who die while on the waiting list (15%) has increased in recent years as a result of severe organ shortages; furthermore the incidence of liver disease is increasing worldwide. Clinical trials involving hepatocyte transplantation have provided encouraging results. However, transplanted cell function appears to often decline after several months, necessitating liver transplantation. The precise aetiology of the loss of cell function is not clear, but poor engraftment and immune-mediated loss appear to be important factors. Also, primary human hepatocytes (PHH) are not readily available, de-differentiate, and die rapidly in culture. Hepatocytes are available from other sources, such as tumour-derived human hepatocyte cell lines and immortalised human hepatocyte cell lines or porcine hepatocytes. However, all these cells suffer from various limitations such as reduced or differences in functions or risk of zoonotic infections. Due to their significant potential, one possible inexhaustible source of hepatocytes is through the directed differentiation of human induced pluripotent stem cells (hiPSCs). This review will discuss the potential applications and existing limitations of hiPSC-derived hepatocytes in regenerative medicine, drug screening, in vitro disease modelling and bioartificial livers., (Copyright © 2016 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
36. An atypical human induced pluripotent stem cell line with a complex, stable, and balanced genomic rearrangement including a large de novo 1q uniparental disomy.
- Author
-
Steichen C, Maluenda J, Tosca L, Luce E, Pineau D, Dianat N, Hannoun Z, Tachdjian G, Melki J, and Dubart-Kupperschmitt A
- Subjects
- Cell Line, Cellular Reprogramming, Humans, Uniparental Disomy pathology, Aneuploidy, Chromosomes, Human, Pair 1 genetics, Fibroblasts pathology, Genome, Human, Induced Pluripotent Stem Cells pathology, Uniparental Disomy genetics
- Abstract
Human induced pluripotent stem cells (hiPSCs) hold great promise for cell therapy through their use as vital tools for regenerative and personalized medicine. However, the genomic integrity of hiPSCs still raises some concern and is one of the barriers limiting their use in clinical applications. Numerous articles have reported the occurrence of aneuploidies, copy number variations, or single point mutations in hiPSCs, and nonintegrative reprogramming strategies have been developed to minimize the impact of the reprogramming process on the hiPSC genome. Here, we report the characterization of an hiPSC line generated by daily transfections of modified messenger RNAs, displaying several genomic abnormalities. Karyotype analysis showed a complex genomic rearrangement, which remained stable during long-term culture. Fluorescent in situ hybridization analyses were performed on the hiPSC line showing that this karyotype is balanced. Interestingly, single-nucleotide polymorphism analysis revealed the presence of a large 1q region of uniparental disomy (UPD), demonstrating for the first time that UPD can occur in a noncompensatory context during nonintegrative reprogramming of normal fibroblasts., (©AlphaMed Press.)
- Published
- 2015
- Full Text
- View/download PDF
37. Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cells.
- Author
-
Dianat N, Dubois-Pot-Schneider H, Steichen C, Desterke C, Leclerc P, Raveux A, Combettes L, Weber A, Corlu A, and Dubart-Kupperschmitt A
- Subjects
- Biomarkers, Cell Differentiation, Cell Lineage, Cell Polarity, Cells, Cultured, Cholagogues and Choleretics pharmacology, Culture Media pharmacology, Human Growth Hormone pharmacology, Humans, Interleukin-6 pharmacology, Taurocholic Acid pharmacology, Transcriptome, Biliary Tract cytology, Cell Culture Techniques methods, Embryonic Stem Cells cytology, Epithelial Cells cytology, Hepatocytes cytology, Pluripotent Stem Cells cytology
- Abstract
Unlabelled: Cholangiocytes are biliary epithelial cells, which, like hepatocytes, originate from hepatoblasts during embryonic development. In this study we investigated the potential of human embryonic stem cells (hESCs) to differentiate into cholangiocytes and we report a new approach, which drives differentiation of hESCs toward the cholangiocytic lineage using feeder-free and defined culture conditions. After differentiation into hepatic progenitors, hESCs were differentiated further into cholangiocytes using growth hormone, epidermal growth factor, interleukin-6, and then sodium taurocholate. These conditions also allowed us to generate cholangiocytes from HepaRG-derived hepatoblasts. hESC- and HepaRG-derived cholangiocyte-like cells expressed markers of cholangiocytes including cytokeratin 7 and osteopontin, and the transcription factors SOX9 and hepatocyte nuclear factor 6. The cells also displayed specific proteins important for cholangiocyte functions including cystic fibrosis transmembrane conductance regulator, secretin receptor, and nuclear receptors. They formed primary cilia and also responded to hormonal stimulation by increase of intracellular Ca(2+) . We demonstrated by integrative genomics that the expression of genes, which signed hESC- or HepaRG-cholangiocytes, separates hepatocytic lineage from cholangiocyte lineage. When grown in a 3D matrix, cholangiocytes developed epithelial/apicobasal polarity and formed functional cysts and biliary ducts. In addition, we showed that cholangiocyte-like cells could also be generated from human induced pluripotent stem cells, demonstrating the efficacy of our approach with stem/progenitor cells of diverse origins., Conclusion: We have developed a robust and efficient method for differentiating pluripotent stem cells into cholangiocyte-like cells, which display structural and functional similarities to bile duct cells in normal liver. These cells will be useful for the in vitro study of the molecular mechanisms of bile duct development and have important potential for therapeutic strategies, including bioengineered liver approaches., (Copyright © 2014 The Authors. HEPATOLOGY published by Wiley on behalf of the American Association for the Study of Liver Diseases.)
- Published
- 2014
- Full Text
- View/download PDF
38. Messenger RNA- versus retrovirus-based induced pluripotent stem cell reprogramming strategies: analysis of genomic integrity.
- Author
-
Steichen C, Luce E, Maluenda J, Tosca L, Moreno-Gimeno I, Desterke C, Dianat N, Goulinet-Mainot S, Awan-Toor S, Burks D, Marie J, Weber A, Tachdjian G, Melki J, and Dubart-Kupperschmitt A
- Subjects
- Cell Differentiation, Cells, Cultured, DNA Copy Number Variations, Gene Expression Profiling methods, Gene Expression Regulation, Developmental, Genotype, Hepatocytes metabolism, Humans, Oligonucleotide Array Sequence Analysis, Phenotype, Polymorphism, Single Nucleotide, Transcription Factors genetics, Cellular Reprogramming, Fibroblasts metabolism, Genetic Vectors, Induced Pluripotent Stem Cells metabolism, RNA, Messenger metabolism, Retroviridae genetics, Transcription Factors metabolism, Transfection methods
- Abstract
The use of synthetic messenger RNAs to generate human induced pluripotent stem cells (iPSCs) is particularly appealing for potential regenerative medicine applications, because it overcomes the common drawbacks of DNA-based or virus-based reprogramming strategies, including transgene integration in particular. We compared the genomic integrity of mRNA-derived iPSCs with that of retrovirus-derived iPSCs generated in strictly comparable conditions, by single-nucleotide polymorphism (SNP) and copy number variation (CNV) analyses. We showed that mRNA-derived iPSCs do not differ significantly from the parental fibroblasts in SNP analysis, whereas retrovirus-derived iPSCs do. We found that the number of CNVs seemed independent of the reprogramming method, instead appearing to be clone-dependent. Furthermore, differentiation studies indicated that mRNA-derived iPSCs differentiated efficiently into hepatoblasts and that these cells did not load additional CNVs during differentiation. The integration-free hepatoblasts that were generated constitute a new tool for the study of diseased hepatocytes derived from patients' iPSCs and their use in the context of stem cell-derived hepatocyte transplantation. Our findings also highlight the need to conduct careful studies on genome integrity for the selection of iPSC lines before using them for further applications., (©AlphaMed Press.)
- Published
- 2014
- Full Text
- View/download PDF
39. Human pluripotent stem cells for modelling human liver diseases and cell therapy.
- Author
-
Dianat N, Steichen C, Vallier L, Weber A, and Dubart-Kupperschmitt A
- Subjects
- Cell Differentiation, Cell- and Tissue-Based Therapy, Drug Discovery, Embryonic Stem Cells cytology, Embryonic Stem Cells transplantation, Hepatocytes cytology, Humans, Induced Pluripotent Stem Cells cytology, Liver cytology, Liver pathology, Liver Failure, Acute pathology, Metabolic Diseases pathology, Hepatocytes transplantation, Induced Pluripotent Stem Cells transplantation, Liver Failure, Acute therapy, Liver Regeneration, Metabolic Diseases therapy
- Abstract
The liver is affected by many types of diseases, including metabolic disorders and acute liver failure. Orthotopic liver transplantation (OLT) is currently the only effective treatment for life-threatening liver diseases but transplantation of allogeneic hepatocytes has now become an alternative as it is less invasive than OLT and can be performed repeatedly. However, this approach is hampered by the shortage of organ donors, and the problems related to the isolation of high quality adult hepatocytes, their cryopreservation and their absence of proliferation in culture. Liver is also a key organ to assess the pharmacokinetics and toxicology of xenobiotics and for drug discovery, but appropriate cell culture systems are lacking. All these problems have highlighted the need to explore other sources of cells such as stem cells that could be isolated, expanded to yield sufficiently large populations and then induced to differentiate into functional hepatocytes. The presence of a niche of "facultative" progenitor and stem cells in the normal liver has recently been confirmed but they display no telomerase activity. The recent discovery that human induced pluripotent stem cells can be generated from somatic cells has renewed hopes for regenerative medicine and in vitro disease modelling, as these cells are easily accessible. We review here the present progresses, limits and challenges for the generation of functional hepatocytes from human pluripotent stem cells in view of their potential use in regenerative medicine and drug discovery.
- Published
- 2013
- Full Text
- View/download PDF
40. Identification of the immunodominant protein and other proteins of the Bacillus anthracis exosporium.
- Author
-
Steichen C, Chen P, Kearney JF, and Turnbough CL Jr
- Subjects
- Amino Acid Sequence, Antibodies, Monoclonal immunology, Antigens, Bacterial genetics, Antigens, Bacterial immunology, Bacillus anthracis chemistry, Bacillus anthracis genetics, Bacillus anthracis physiology, Bacterial Proteins genetics, Bacterial Proteins immunology, Immunodominant Epitopes genetics, Immunodominant Epitopes immunology, Membrane Glycoproteins chemistry, Membrane Glycoproteins genetics, Membrane Glycoproteins immunology, Molecular Sequence Data, Spores, Bacterial immunology, Antigens, Bacterial chemistry, Bacillus anthracis immunology, Bacterial Proteins chemistry, Immunodominant Epitopes chemistry
- Abstract
Spores of Bacillus anthracis, the causative agent of anthrax, are enclosed by a prominent loose-fitting, balloon-like layer called the exosporium. Although the exosporium serves as the source of surface antigens and a primary permeability barrier of the spore, its molecular structure and function are not well characterized. In this study, we identified five major proteins in purified B. anthracis (Sterne strain) exosporia. One protein was the recently identified collagen-like glycoprotein BclA, which appears to be a structural component of the exosporium hair-like nap. Using a large panel of unique antispore monoclonal antibodies, we demonstrated that BclA is the immunodominant antigen on the B. anthracis spore surface. We also showed that the BclA protein and not a carbohydrate constituent directs the dominant immune response. In addition, the length of the central (GXX)(n) repeat region of BclA appears to be strain specific. Two other unique proteins, BxpA and BxpB, were identified. BxpA is unusually rich in Gln and Pro residues and contains several different tandem repeats, which also exhibit strain-specific variation. In addition, BxpA was found to be cleaved approximately in half. BxpB appears to be glycosylated or associated with glycosylated material and is encoded by a gene that (along with bclA) may be part of an exosporium genomic island. The other two proteins identified were alanine racemase and superoxide dismutase, both of which were reported to be associated with the surface of other Bacillus spores. Possible functions of the newly identified proteins are discussed.
- Published
- 2003
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.